Literature DB >> 22079987

Inducible CD4+LAP+Foxp3- regulatory T cells suppress allergic inflammation.

Wei Duan1, Takanori So, Amit K Mehta, Heonsik Choi, Michael Croft.   

Abstract

Regulatory T cells (Tregs) play a critical role in the maintenance of airway tolerance. We report that inhaled soluble Ag induces adaptive Foxp3(+) Tregs, as well as a regulatory population of CD4(+) T cells in the lungs and lung-draining lymph nodes that express latency-associated peptide (LAP) on their cell surface but do not express Foxp3. Blocking the cytokine IL-10 or TGF-β prevented the generation of LAP(+) Tregs and Foxp3(+) Tregs in vivo, and the LAP(+) Tregs could also be generated concomitantly with Foxp3(+) Tregs in vitro by culturing naive CD4(+) T cells with Ag and exogenous TGF-β. The LAP(+) Tregs strongly suppressed naive CD4(+) T cell proliferation, and transfer of sorted OVA-specific LAP(+) Tregs in vivo inhibited allergic eosinophilia and Th2 cytokine expression in the lung, either when present at the time of Th2 sensitization or when injected after Th2 cells were formed. Furthermore, inflammatory innate stimuli from house dust mite extract, nucleotide-binding oligomerization domain containing 2 ligand, and LPS, which are sufficient for blocking airway tolerance, strongly decreased the induction of LAP(+) Tregs. Taken together, we concluded that inducible Ag-specific LAP(+) Tregs can suppress asthmatic lung inflammation and constitute a mediator of airway tolerance together with Foxp3(+) Tregs.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22079987      PMCID: PMC3237738          DOI: 10.4049/jimmunol.1101398

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  51 in total

1.  Transforming growth factor-beta controls development, homeostasis, and tolerance of T cells by regulatory T cell-dependent and -independent mechanisms.

Authors:  Ming O Li; Shomyseh Sanjabi; Richard A Flavell
Journal:  Immunity       Date:  2006-09       Impact factor: 31.745

2.  Oral CD3-specific antibody suppresses autoimmune encephalomyelitis by inducing CD4+ CD25- LAP+ T cells.

Authors:  Hirofumi Ochi; Michal Abraham; Hiroki Ishikawa; Dan Frenkel; Kaiyong Yang; Alexandre S Basso; Henry Wu; Mei-Ling Chen; Roopali Gandhi; Ariel Miller; Ruth Maron; Howard L Weiner
Journal:  Nat Med       Date:  2006-05-21       Impact factor: 53.440

3.  Naturally occurring lung CD4(+)CD25(+) T cell regulation of airway allergic responses depends on IL-10 induction of TGF-beta.

Authors:  Anthony Joetham; Katsuyuki Takeda; Katsuyuki Takada; Christian Taube; Nobuaki Miyahara; Shigeki Matsubara; Satoko Matsubara; Toshiyuki Koya; Yeong-Ho Rha; Azzeddine Dakhama; Erwin W Gelfand
Journal:  J Immunol       Date:  2007-02-01       Impact factor: 5.422

4.  Inhibition of autoimmune diabetes by oral administration of anti-CD3 monoclonal antibody.

Authors:  Hiroki Ishikawa; Hirofumi Ochi; Mei-Ling Chen; Dan Frenkel; Ruth Maron; Howard L Weiner
Journal:  Diabetes       Date:  2007-04-24       Impact factor: 9.461

5.  Expansion of circulating Foxp3+)D25bright CD4+ T cells during specific venom immunotherapy.

Authors:  M C Pereira-Santos; A P Baptista; A Melo; R R Alves; R S Soares; E Pedro; M Pereira-Barbosa; R M M Victorino; A E Sousa
Journal:  Clin Exp Allergy       Date:  2007-12-07       Impact factor: 5.018

6.  Granzyme B and perforin are important for regulatory T cell-mediated suppression of tumor clearance.

Authors:  Xuefang Cao; Sheng F Cai; Todd A Fehniger; Jiling Song; Lynne I Collins; David R Piwnica-Worms; Timothy J Ley
Journal:  Immunity       Date:  2007-10-04       Impact factor: 31.745

7.  Cutting edge: high molecular weight hyaluronan promotes the suppressive effects of CD4+CD25+ regulatory T cells.

Authors:  Paul L Bollyky; James D Lord; Susan A Masewicz; Stephen P Evanko; Jane H Buckner; Thomas N Wight; Gerald T Nepom
Journal:  J Immunol       Date:  2007-07-15       Impact factor: 5.422

8.  Histamine 4 receptor activation induces recruitment of FoxP3+ T cells and inhibits allergic asthma in a murine model.

Authors:  Ross K Morgan; Brian McAllister; Lillian Cross; Daniel S Green; Hardy Kornfeld; David M Center; William W Cruikshank
Journal:  J Immunol       Date:  2007-06-15       Impact factor: 5.422

9.  Absence of integrin-mediated TGFbeta1 activation in vivo recapitulates the phenotype of TGFbeta1-null mice.

Authors:  Zhiwei Yang; Zhenyu Mu; Branka Dabovic; Vladimir Jurukovski; Dawen Yu; Joanne Sung; Xiaozhong Xiong; John S Munger
Journal:  J Cell Biol       Date:  2007-03-12       Impact factor: 10.539

10.  Latency associated peptide has in vitro and in vivo immune effects independent of TGF-beta1.

Authors:  Naeem A Ali; Alice A Gaughan; Charles G Orosz; Chris P Baran; Sara McMaken; Yijie Wang; Timothy D Eubank; Melissa Hunter; Frank J Lichtenberger; Nicholas A Flavahan; Jack Lawler; Clay B Marsh
Journal:  PLoS One       Date:  2008-04-02       Impact factor: 3.240

View more
  35 in total

Review 1.  Control of regulatory T cells and airway tolerance by lung macrophages and dendritic cells.

Authors:  Wei Duan; Michael Croft
Journal:  Ann Am Thorac Soc       Date:  2014-12

2.  Epicutaneous immunotherapy induces gastrointestinal LAP+ regulatory T cells and prevents food-induced anaphylaxis.

Authors:  Leticia Tordesillas; Lucie Mondoulet; Ana Belen Blazquez; Pierre-Henri Benhamou; Hugh A Sampson; M Cecilia Berin
Journal:  J Allergy Clin Immunol       Date:  2016-06-11       Impact factor: 10.793

3.  Characterization and functional studies of forkhead box protein 3(-) lymphocyte activation gene 3(+) CD4(+) regulatory T cells induced by mucosal B cells.

Authors:  K-H Chu; B-L Chiang
Journal:  Clin Exp Immunol       Date:  2015-05       Impact factor: 4.330

4.  TGF-β-mediated airway tolerance to allergens induced by peptide-based immunomodulatory mucosal vaccination.

Authors:  H Michael; Y Li; Y Wang; D Xue; J Shan; B D Mazer; C T McCusker
Journal:  Mucosal Immunol       Date:  2015-03-18       Impact factor: 7.313

Review 5.  Oxidative stress and cellular pathways of asthma and inflammation: Therapeutic strategies and pharmacological targets.

Authors:  Vikas Mishra; Jaspreet Banga; Patricia Silveyra
Journal:  Pharmacol Ther       Date:  2017-08-23       Impact factor: 12.310

6.  Rhinovirus infection interferes with induction of tolerance to aeroantigens through OX40 ligand, thymic stromal lymphopoietin, and IL-33.

Authors:  Amit K Mehta; Wei Duan; Astrid M Doerner; Suzanne L Traves; David H Broide; David Proud; Bruce L Zuraw; Michael Croft
Journal:  J Allergy Clin Immunol       Date:  2015-06-19       Impact factor: 10.793

Review 7.  Immunological mechanisms for desensitization and tolerance in food allergy.

Authors:  Rima Rachid; Dale T Umetsu
Journal:  Semin Immunopathol       Date:  2012-07-21       Impact factor: 9.623

Review 8.  Genetic evidence for the role of transforming growth factor-β in atopic phenotypes.

Authors:  Katherine A Weissler; Pamela A Frischmeyer-Guerrerio
Journal:  Curr Opin Immunol       Date:  2019-06-01       Impact factor: 7.486

9.  Cutting edge: 4-1BB controls regulatory activity in dendritic cells through promoting optimal expression of retinal dehydrogenase.

Authors:  Seung-Woo Lee; Yunji Park; So-Young Eun; Shravan Madireddi; Hilde Cheroutre; Michael Croft
Journal:  J Immunol       Date:  2012-08-15       Impact factor: 5.422

10.  Nod2 deficiency is associated with an increased mucosal immunoregulatory response to commensal microorganisms.

Authors:  A Amendola; A Butera; M Sanchez; W Strober; M Boirivant
Journal:  Mucosal Immunol       Date:  2013-08-21       Impact factor: 7.313

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.